Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
1.030
-0.010 (-0.96%)
At close: May 26, 2026, 4:00 PM EDT
1.010
-0.020 (-1.94%)
After-hours: May 26, 2026, 8:00 PM EDT
Myomo Revenue
Myomo had revenue of $10.11M in the quarter ending March 31, 2026, with 2.86% growth. This brings the company's revenue in the last twelve months to $41.21M, up 6.68% year-over-year. In the year 2025, Myomo had annual revenue of $40.93M with 25.73% growth.
Revenue (ttm)
$41.21M
Revenue Growth
+6.68%
P/S Ratio
0.97
Revenue / Employee
$211,331
Employees
195
Market Cap
39.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.93M | 8.38M | 25.73% |
| Dec 31, 2024 | 32.55M | 13.31M | 69.17% |
| Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
| Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
| Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
| Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
| Dec 31, 2019 | 3.84M | 1.39M | 57.02% |
| Dec 31, 2018 | 2.44M | 885.23K | 56.79% |
| Dec 31, 2017 | 1.56M | 455.59K | 41.29% |
| Dec 31, 2016 | 1.10M | 413.61K | 59.97% |
| Dec 31, 2015 | 689.67K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 428.57M |
| Nortech Systems | 121.79M |
| TELA Bio | 80.81M |
| Baird Medical Investment Holdings | 22.54M |
| Sensus Healthcare | 22.53M |
| NeuroOne Medical Technologies | 12.72M |
| Elutia | 12.46M |
| InspireMD | 10.85M |
MYO News
- 5 days ago - Myomo Transcript: Sidoti Micro-Cap Virtual Conference - Transcripts
- 6 days ago - Myomo Transcript: A.G.P.'s Annual Virtual Healthcare Conference - Transcripts
- 6 days ago - Myomo Slides: Investor presentation - Filings
- 12 days ago - Myomo Announces Participation in Upcoming Investor Conferences - Business Wire
- 12 days ago - Myomo Proxy statement: Proxy filing - Filings
- 12 days ago - Myomo Proxy statement: Proxy filing - Filings
- 12 days ago - Myomo Slides: Corporate presentation - Filings
- 13 days ago - Myomo Appoints Joseph M. Manko to its Board of Directors - Business Wire